• GLP-1 (9-36) amide: Benchmark Antagonist for GLP-1R Studies

  2026-05-25

  GLP-1 (9-36) amide enables unparalleled specificity in dissecting GLP-1 receptor signaling, overcoming pitfalls of receptor cross-talk and off-target effects. This guide synthesizes best practices, troubleshooting, and translational insights for robust metabolic and type 2 diabetes research workflows.

• HyperFluor 488 Goat Anti-Human IgG Antibody: Workflow & Inno

  2026-05-25

  The HyperFluor™ 488 Goat Anti-Human IgG (H+L) Antibody delivers exceptional sensitivity and versatility for immunofluorescence, Western blot, and flow cytometry workflows. Its Alexa Fluor 488 conjugation, robust specificity, and signal amplification capability position it as a best-in-class reagent for reliable, high-throughput human IgG detection in advanced biomedical research.

• BML-277: Advanced Chk2 Inhibition for Nuclear cGAS Pathway I

  2026-05-24

  Explore how BML-277, a potent Chk2 inhibitor, uniquely enables investigation of the nuclear cGAS–TRIM41 axis in DNA damage response research. Gain actionable protocol guidance and critical insights for radioprotection studies and genome stability assays.

• Antibacterial Drug Use and Resistance in Psychiatric Hospita

  2026-05-23

  This study provides a nuanced analysis of antibacterial drug use and bacterial resistance patterns in a psychiatric hospital during the COVID-19 epidemic. By leveraging hospital data and national surveillance, the research highlights rational antibiotic deployment and identifies the complex interplay between antimicrobial selection and emerging resistance, with practical implications for infection control policy.

• YTHDF2 Inhibition Enhances Hippocampal Memory via m6A mRNA R

  2026-05-22

  This study reveals that inhibiting YTHDF2-mediated m6A mRNA degradation in the mouse forebrain promotes synaptic protein synthesis and enhances hippocampus-dependent memory. The findings clarify the mechanistic role of YTHDF2 in regulating mRNA fate and neuronal plasticity, with implications for translational neuroscience and neuroepigenetic research.

• Levofloxacin (SKU B1959): Reliable Strategies for Cell Assay

  2026-05-22

  This article equips biomedical researchers with scenario-driven guidance for leveraging Levofloxacin (SKU B1959) as a synthetic fluoroquinolone antibiotic in cell viability and bone metabolism assays. Drawing on peer-reviewed data and validated workflows, it addresses common pain points in experimental reproducibility, assay optimization, and product selection, ensuring that users maximize both scientific rigor and operational efficiency.

• Screening MMV Compounds Against MDR Bacterial and Fungal Iso

  2026-05-21

  This study evaluates the MMV Pandemic Response Box for activity against multidrug-resistant Acinetobacter baumannii, Pseudomonas aeruginosa, and major fungal pathogens. Several compounds demonstrated potent inhibitory or bactericidal effects, setting new benchmarks for antimicrobial screening assays and informing translational research on novel antibacterial and antifungal agents.

• AMPK Inhibits Autophagy: Revisiting Cellular Energy Stress R

  2026-05-21

  A recent study overturns the prevailing model of AMPK-mediated autophagy by demonstrating that AMPK activation suppresses, rather than induces, ULK1 activity and autophagy initiation during energy stress. These findings refine our understanding of metabolic adaptation and inform the use of AMPK activators like A-769662 in energy metabolism and autophagy research.

• Pharmacokinetics and Efficacy of Cefazedone in Community-Acq

  2026-05-20

  This article examines a prospective clinical study evaluating the pharmacokinetic and pharmacodynamic rationale of intravenous cefazedone sodium for mild to moderate community-acquired pneumonia. The findings provide quantitative support for current dosing regimens and reveal strong clinical-microbiological correlation, informing translational research and future protocol design.

• Pazopanib Hydrochloride: Protocols and Applications in Cance

  2026-05-20

  Pazopanib Hydrochloride (GW786034) empowers oncology researchers with robust multi-target inhibition, enabling nuanced studies of angiogenesis and tumor suppression. This guide translates leading-edge reference findings and best practices into actionable workflows—maximizing assay reliability and experimental insight.

• Selective Spectrophotometric Analysis of Phenolic β-Lactam A

  2026-05-19

  The reference study introduces two rapid, selective spectrophotometric methods for quantifying phenolic β-lactam antibiotics, with robust accuracy even in complex pharmaceutical formulations containing combinations such as amoxicillin and dicloxacillin. This innovation addresses limitations of standard chromatographic assays, enhancing workflow accessibility and precision for researchers monitoring β-lactam antibiotic content.

• Selective Inhibition of SARS-CoV-2 PLpro by Aloin Isoforms:

  2026-05-19

  The referenced study demonstrates that aloin A and B, compounds found in certain oral rinse ingredients, selectively inhibit the proteolytic and deubiquitinating activities of SARS-CoV-2 PLpro in vitro, while other tested agents such as Hexetidine do not show this effect. These findings clarify the molecular basis for antiviral effects observed with select oral rinses and guide the rational design of oral antimicrobial strategies for infection control.

• Sodium Dicloxacillin Monohydrate: Advanced MSSA Research Wor

  2026-05-18

  Sodium dicloxacillin monohydrate empowers precise, reproducible modeling of methicillin-sensitive Staphylococcus aureus (MSSA) infections in both intra- and extracellular contexts. This guide translates gold-standard reference findings into actionable protocols and troubleshooting strategies, ensuring robust antibiotic mechanism alignment for Gram-positive infection research.

• Bafilomycin A1: Precision V-ATPase Inhibitor for Stem Cell R

  2026-05-18

  Bafilomycin A1 unlocks high-sensitivity, reversible control of V-ATPase activity in lysosomal and mitophagy workflows, enabling cell biologists to dissect intracellular pH regulation and stem cell differentiation with nanomolar precision. Leveraging insights from recent stem cell research and validated protocol enhancements, APExBIO’s Bafilomycin A1 stands out for reproducibility, versatility, and troubleshooting support across advanced scenarios.

• Cefiderocol Outperforms β-Lactamase Inhibitors in Resistant

  2026-05-17

  This large European study demonstrates that cefiderocol maintains superior in vitro activity against Enterobacterales, including isolates resistant to both meropenem and β-lactam/β-lactamase inhibitor combinations. The findings inform susceptibility testing strategies and highlight the need for robust PK/PD modeling in multidrug-resistant Gram-negative infections.

452 records 17/31 page Previous Next First page 上5页 1617181920 下5页 Last page